Atherosclerotic identification
US5046501A · kind A · utility
197Cited by
5References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 18, 1989 |
| Grant date | Sep 10, 1991 |
| Priority date | — |
| Expiry date | Jan 18, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B2018/00904
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A method of identifying atherosclerotic plaque versus structurally viable tissue includes the steps of emitting a fluorescent beam at a single excitation wavelength of between 350 and 390 nm at a tissue and detecting and quantifying the emission spectrum of the emitted beam at critical points chosen to optimize the difference between atherosclerotic plaque and structurally viable tissue. The presence of the atherosclerotic plaque is distinguished from structurally viable tissue by the presence or absence of the intensity of emissions at the critical points of optimum distinguishing wavelengths. 8
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.